ConvEyXO

ConvEyXO is a France-based biotechnology company dedicated to developing the next generation of engineered extracellular vesicles (EVs), commonly known as exosomes, for therapeutic use. The company's proprietary platform focuses on producing Large Extracellular Vesicles (L-EVs) that are bio-engineered to carry specific biological cargoes tailored for regenerative medicine and inflammatory diseases. ConvEyXO's lead programs target high unmet needs in orthopedics, specifically osteoarthritis and cartilage repair, as well as ophthalmology and neuro-inflammatory disorders. By leveraging the natural ability of exosomes to cross biological barriers and deliver complex molecular messages, the company aims to provide more precise and scalable alternatives to traditional cell therapies.